August 30, 2018 / 5:29 AM / 22 days ago

CORRECTED-BRIEF-Vistin Pharma Q2 Adjusted EBITDA Nok 2.3 Million

(Corrects figures in third bullet)

Aug 30 (Reuters) - VISTIN PHARMA ASA:

* REG-VISTIN PHARMA ASA : 20 PER CENT REVENUE GROWTH IN SECOND QUARTER 2018

* Q2 REVENUE NOK 54.6 MILLION VERSUS NOK 45.3 MILLION YEAR AGO

* Q2 ADJ EBITDA NOK 2.3 MLN VS NOK 3.5 MLN YR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below